Device Therapies in the Post-Myocardial Infarction Patient with Left Ventricular Dysfunction

Alan H. Kadish, James A. Reiffel, Gerald V. Naccarelli, John P. DiMarco

Research output: Contribution to journalArticlepeer-review

4 Scopus citations


The post-myocardial infarction (MI) patient with left ventricular dysfunction (LVD) is at risk for ventricular arrhythmias resulting in sudden cardiac death. In high-risk post-MI patients with a depressed left ventricular ejection fraction, prophylactic implantable cardioverter defibrillators (ICDs) may significantly improve survival. These benefits are in addition to those of optimal pharmacologic therapy, and ICD therapy should be considered the standard of care in these patients. Recent device trials have demonstrated the benefits of prophylactic ICD placement in patients who have been selected based on post-MI left ventricular systolic dysfunction alone. In addition, cardiac resynchronization therapy can improve the quality of life beyond that achievable with drug therapy alone and should be considered in patients with symptomatic heart failure with QRS prolongation. Further risk stratification studies of post-MI LVD patients will allow ICD therapy to be applied in a more cost-effective manner.

Original languageEnglish (US)
Pages (from-to)29G-37G
JournalAmerican Journal of Cardiology
Issue number5 SUPPL.
StatePublished - Sep 8 2008

All Science Journal Classification (ASJC) codes

  • Cardiology and Cardiovascular Medicine


Dive into the research topics of 'Device Therapies in the Post-Myocardial Infarction Patient with Left Ventricular Dysfunction'. Together they form a unique fingerprint.

Cite this